HomeCategory

News/Media

VitriVax Co-Founder Ted Randolph Named a “Giant of Biopharmaceutical Science and Engineering” By The Journal of Pharmaceutical Science

January 20, 2020

VitriVax Licensee Soligenix Announces Phase 1 Clinical Trials of Thermostable Ricin Vaccine, RiVax

December 21, 2019

Breakthroughs in global health

September 29, 2018

A shot in the arm: New shelf-stable vaccines could bolster lifesaving immunization deliveries worldwide

June 1, 2017

$1.1 million grant funds CU Boulder research into next-generation vaccines

November 4, 2016